Related Experiment Video
Updated: May 20, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Personality and hormone therapy use among postmenopausal women in the GAZEL cohort study
Cédric Lemogne1, Silla M Consoli, Henri Panjo
1Faculté de médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. cedric.lemogne@egp.aphp.fr
Objective:
To examine with a prospective design the association of personality with hormone therapy (HT) use before and after the publication of the Women's Health Initiative (WHI) trial.
Design:
Questionnaires were mailed to measure type A personality and hostility. Additional data from up to six mailed questionnaires every 3 years were used to determine the subsequent date of menopause and the use of HT. The association between personality and HT use was measured by the relative index of inequality computed through binary logistic regression.
Setting:
The French GAZEL Cohort Study.
Patient(S):
Women (n = 1,803) who reached natural menopause during the study.
Intervention(S):
None.
Main Outcome Measure(S):
Hormone therapy use within 1 year after the date of menopause.
Result(S):
Hormone therapy use (916 users vs. 887 nonusers) was associated with type A personality (relative index of inequality = 1.88, 95% confidence interval = 1.35-2.63). This association remained significant after adjustment for all potential confounders (relative index of inequality = 1.84, 95% confidence interval = 1.23-2.74). There was no significant interaction between type A personality and the date of menopause as regards the WHI publication.
Conclusion(S):
Type A personality may be associated with HT use among postmenopausal women, regardless of other predictors, including vascular and breast cancer risk factors.
Related Concept Videos
Menopause
Hormonal Regulation
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...